Approaches for Solubility Enhancement in Pharmaceutical Drug Development: A Comprehensive Review
Year: 2026
Type: article
Abstract: Retention mechanisms in biological systems help transport essential organic and inorganic substances into the body and maintain their bioavailability. One of the major reasons for poor bioavailability of drugs is inadequate solubility or permeability. Among these, poor aqueous solubility is the most common problem faced by many drug molecules. With the continuous advancement in pharmaceutical and chemical sciences, the need for developing new drug delivery technologies has increased, and the selection of technology depends on the specific properties of each drug. Many drugs exhibit very low water solubility, which limits their dissolution rate in the gastrointestinal tract. Since drug dissolution is a rate-limiting step for absorption, poor solubility directly affects therapeutic effectiveness. The oral route is the most convenient and widely preferred method for drug administration because of its ease of use and patient compliance. According to the Biopharmaceutics Classification System (BCS), drugs are divided into four classes based on solubility and permeability. Solubility-related challenges are mainly observed in BCS Class II and Class IV drugs. To improve the solubility and bioavailability of poorly soluble drugs, various techniques and strategies are applied. These methods include physical and chemical modification of drug substances, particle size reduction, and the use of solubility enhancement technologies. The selection of an appropriate solubility enhancement method depends on several factors such as drug properties, absorption site, and desired dosage form characteristics.
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7148853867
